Operator of a drug formulation development company intended to transform intravenous, injectable, and oral therapeutics into novel orally delivered medicines. The company's products help in the conversion of intravenous or injectable xenobiotics into orally deliverable substances, as well as make it easy for hydrophobic compounds to be absorbed in the small intestine, enabling physicians to permit oral dosing of pharmaceutical compounds that have previously been administered intravenously or by injection.